item management discussion and analysis of financial condition and results of operations 
overview esc is a world leader in the design  manufacture  marketing and servicing of a broad range of medical devices that incorporate proprietary ipl technology  state of the art lasers and accessories as well as other technologies 
the company s systems incorporate these technologies for applications in aesthetic dermatology  plastic and reconstructive surgery  ear  nose and throat procedures and oral and dental surgery  among others 
the company s systems are designed for use in a variety of medical environments  ranging from physicians offices to acute care hospitals 
starting in  the company organized itself into three business units one unit consisting of three geographical sub units serving the aesthetic and surgical market  one unit serving the dental market and one unit serving the industrial market 
as of december   most of the restructuring plan initiated in september was implemented 
certain remaining cost savings measures are still planned 
in this report  unless the context otherwise requires  all references to the company are to esc and its direct and indirect wholly owned subsidiaries 
year ended december  compared with year ended december  in thousands of dollars net sales 
the company s net sales increased by to approximately  in compared to approximately  in the increase in sales is attributable to an increase in unit sales and sale of services 
gross profit 
gross profit increased to approximately  in from approximately  in excluding the write off of inventory and other reserves mainly relating to restructuring  gross profit for the year was  as a percentage of sales  the gross profit was in compared to in  excluding the write off of inventory and other reserves 
the significant increase in gross profit is due to the increase in sales  reduction in overhead cost and an improvement in the product mix 
research and development costs  net 
net research and development costs in decreased by to approximately  from approximately  in as a percentage of sales  research and development costs were in as compared to in the decrease in research and development costs  net is due to a reduction in overhead costs  significantly lower material consumption and cost savings implemented during  including the elimination of certain uneconomical projects 
research and development expenses are net of the participation of the office of the chief scientist in israel 
selling  marketing and administrative expenses 
selling  marketing and administrative expenses decreased by to approximately  in from approximately  in as a percentage of sales  selling  marketing and administrative expenses were in compared to in selling  marketing and administrative expenses for included bad debt charges of  restructuring charges of  and litigation expenses of  which were not part of the legal settlements which were recorded in settlement of litigations described below 
excluding write offs relating to the restructuring  bad debts and litigation expenses in  selling  marketing and administrative expense were  as a percentage of sales  selling  marketing and administrative expenses in were compared to in  excluding write offs and litigation expense 
the decrease in is attributable to the reduction in selling and marketing costs  mainly in the united states  as a result of the restructuring plan adopted during and the decrease in general and administrative expenses mainly attributable to a decrease in bad debts reserves and a significant reduction in legal costs 
restructuring costs 
in  the company developed and started the implementation of a restructuring plan 
the majority of the restructuring charge was attributable to the company s divisions in the united states 
the restructuring program provides for a reduction of approximately employees 
settlement of litigations 
during  the company had made several legal settlements mainly related to the reliant and lpg lawsuits 
the total amounts for the legal settlements was  which includes both settlement fees and related legal fees incurred by the company see item legal proceedings above 
write off of intangible and tangible assets 
during  the company wrote off intangible assets for the amount of  which mainly related to goodwill from acquisitions and acquired technology in prior years 
in addition  the company wrote off tangible assets in the amount of  that related to the restructuring plan adopted during other expenses 
for the year ended december   other expenses were  comprised mainly of fees to the mckinsey co  work on the restructuring plan and  of expenses incurred during in connection with the election contest relating to the company s june  combined annual and extraordinary general meeting of shareholders 
other operating income 
other operating income in includes the profit from sale of operation of a unit in our industrial division  applied optronics corporation in the united states 
operating income loss 
for the year  operating profit was  representing of sales compared to operating loss of  for the improvement in operating result is due to the adoption of the restructuring plan  mainly designed to align the company s cost structure with its revenue  the increase in sales and improvement in gross margins and the sale of applied optronics corporation 
other income 
other income of in includes profits due to dilution of the company s interests in one of its high tech ventures  galil medical ltd 
financing income expense  net 
for the year ended december   financing expenses were approximately  compared to financing expenses of  in financing expense increased mainly due to lower cash available 
taxes on income 
taxes on income were approximately for the year ended december  compared to approximately  for the year ended december  in  the company wrote off deferred tax assets of approximately  which is reflected as tax expense in the period 
because most of the company s income in israel is presently exempt from income taxes  the israeli statutory tax rate for the purposes of the reconciliation of the reported tax expense is approximately zero 
additionally  the company has over million of net operating losses  mostly in the united states and israel 
income tax expense in the financial statements relates primarily to the income taxes of non israeli subsidiaries 
company s share on losses of affiliates 
company s share on losses of affiliates in was  compared to in extraordinary gain on purchase of the company s subordinated convertible notes 
extraordinary gain on the purchase of the company s convertible notes was compared to  in the decrease is due to the purchase of fewer of the company s convertible notes 
net income 
as a result of the foregoing factors  the company s net income in was  compared to net loss of  in the improvement in net income is due to the adoption of the restructuring plan  mainly designed to align the company s cost structure with its revenue capabilities  the increase in sales and improvement in gross margins and the sale of applied optronics corp 
year ended december  compared with year ended december  in thousands of dollars net sales 
the company s net sales decreased by to approximately  in compared to approximately  in in  net sales decreased due to a decrease in unit sales and lower selling prices in the united states aesthetic market 
the competitive price pressure mainly on hair removal products resulted in lower price and lower unit sales of the company s high margin products 
in addition  sales are reflected net of reserves for sales returns 
gross profit 
gross profit decreased by to approximately  in from approximately  in gross profits decreased mainly due to the reduction in sales 
in addition  in  the company recorded inventory write off and other charges of approximately  gross profit for the year ended december  was compared to in excluding a write off of inventory and other reserves  gross profits for the year ended december  was  or compared to  or in research and development costs  net 
net research and development costs in decreased by to approximately  from approximately  in as a percentage of sales  research and development costs were in as compared to in the decrease in research and development costs net is due to a reduction in staff and lower material consumption 
research and development expenses are net of the participation of the office of the chief scientist in israel 
selling  marketing and administrative expenses 
selling  marketing and administrative expenses increased by to approximately  in from approximately  in as a percentage of sales  selling  marketing and administrative expenses were in compared to in the increase in selling  marketing and administrative expenses as a percentage of sales was mainly due to the lower level of sales in increased selling  marketing and administrative expenses in were primarily attributed to the expansion and reorganization of the company s selling efforts in the united states 
selling  marketing and administrative expenses include  which related to the restructuring plan adopted in  bad debt charges of  and litigation expenses of  which were not part of the legal settlements which were recorded in settlement of litigations described below 
restructuring costs 
in the quarter ended march   the company developed and started the implementation of a restructuring plan 
in connection with that restructuring plan  the company recorded charges in of  related to its sales and marketing operations and  related to inventory write off included in the cost of goods sold 
in the third quarter of  the company commenced another restructuring program 
in connection with that restructuring program  the company recorded write downs of inventories included in cost of goods sold of approximately  the restructuring charge which amounted to  is comprised of writedowns of fixed assets of  and severance charges and a lease contract termination cost of  the majority of the restructuring charge was attributable to the company s divisions in the united states 
the restructuring program provides for a reduction of approximately employees 
in addition  the company recorded  of expenses associated with the same plan which was charged to operating and income tax expense 
settlement of litigations 
during the company had made several legal settlements mainly related to the reliant and lpg lawsuits 
the total amounts for the legal settlements was  which includes both settlement fees and related legal fees incurred by the company see item legal proceedings above 
write off of intangible and tangible assets 
during  the company wrote off intangible assets for the amount of  which mainly related to goodwill from acquisitions and acquired technology in prior years 
in addition  the company wrote off tangible assets in the amount of  that related to the restructuring plan adopted during acquired research and development 
in  there was  of acquired research and development expenses in connection with the acquisition of technology from ballard purchase corporation 
other expenses 
for the year ended december   other expenses were  comprised mainly of the following fees in the amount of  related to the mckinsey co 
work on the restructuring plan 
 of expenses incurred during in connection with the election contest relating to the company s june  combined annual and extraordinary general meeting of shareholders 
the election contest resulted in the reimbursement of expenses incurred by certain shareholders in connection with the election contest  in accordance with the resolution adopted by the board of directors and the audit committee of the company  during a meeting held on june   which resolved that all costs and expenses of messrs 
arie genger and barnard j 
gottstein and their affiliates in connection with the election contest shall be reimbursed by the company promptly on submission of invoices therefor  subject to refund when such reimbursement is submitted to shareholders and not approved by such shareholders at a meeting noticed for such purpose 
the company intends to present the foregoing expense reimbursement arrangement to shareholders for approval at the next annual general meeting of shareholders 
messrs 
genger and gottstein have submitted to the company invoices for a sum of approximately  separate from these shareholder incurred expenses  the officers and directors of the company incurred expenses of  in connection with the election contest that were charged to the company 
operating income loss financing income expense  net 
for the year ended december   financing expenses were approximately  from financing income of  in financing income in consisted of interest income of  from the company s short term and long term investment securities which was offset by interest and amortization of deferred expenses  in the amount of  attributable to the company s subordinated convertible notes and by other interest and exchange rate differences of  at december   approximately  was invested in short term bank deposits 
non recurring expenses 
for the year ended december   the company incurred expenses in the amount of  related to the costs associated with the laser industries acquisition 
taxes on income 
taxes on income were approximately  for the year ended december  compared to approximately  for the year ended december  in the company wrote off deferred tax assets of approximately  which is reflected as tax expense in the period 
because most of the company s income in israel is presently exempt from income taxes  the israeli statutory tax rate for the purposes of the reconciliation of the reported tax expense is approximately zero 
income tax expense in the financial statements relates primarily to the income taxes of non israeli subsidiaries 
extraordinary gain on purchase of the company s subordinated convertible notes 
during the company had purchased  principal amount of its subordinated convertible notes 
as a result of the repurchase the company had an extraordinary income of approximately  net income 
as a result of the foregoing factors  the company s net loss was  in from a net income of approximately  in variability of operating results the company s sales and profitability may vary in any given year  and from quarter to quarter  depending on the number and mix of products sold and the average selling price of the products 
in addition  due to potential competition  uncertain market acceptance and other factors  the company may be required to reduce prices for its products in the future 
the company s future results will be affected by a number of factors including the ability to increase the number of units sold  to develop  introduce and deliver new products on a timely basis  to anticipate accurately customer demand patterns and to manage future inventory levels in line with anticipated demand 
these results may also be affected by currency exchange rate fluctuations and economic conditions in the geographical areas in which the company operates 
there can be no assurance that the company s historical growth in sales  gross profit and net income will continue  or that sales  gross profit and net income in any particular quarter will not be lower than those of the preceding quarters  including comparable quarters 
liquidity and capital resources in thousands of dollars as of december   the company had cash and cash equivalents of  compared to  on december  the increase of  is mainly attributable to operating activities in  cash used by operating activities was approximately  the primary cash used in the company s operating activities was approximately  for payment of legal settlements  approximately  for payments in respect of restructuring  negative change in current working capital of approximately  mainly due to an increase of  in inventories  decrease of  in accounts payable and accrued expenses and an increase of  in trade receivables all offset by the profit in the increase of inventories is due to preparation for a continuous increase in sales and the manufacture of hair removal machines for the aculight program 
under the aculight program  machines owned by the company are placed with operators who are charged per usage fees 
nevertheless aggressive program has been initiated to reduce inventory levels 
investing activities in  cash provided by investing activities was approximately  the primary changes in the company s investing activities were the maturity of  in short term investments which was partially used in operating activities  use of cash of approximately  to purchase fixed assets  proceeds of approximately from sales of fixed assets  a  investment representing approximately control of the voting power in a company  investment in galil medical systems ltd 
and a in proceeds from sale of a unit in our industrial division 
financing activities in  cash provided by financing activities was  the primary financing activities of the company included the repurchase of the company s subordinated convertible notes for  proceeds from the exercise of options of  and a short term loan of  esc has executed commitment letters with two leading israeli banks to finance the transaction to acquire the operations of cmg 
in accordance with the commitment letters  esc will be provided with up to million in financing to consist of a million six year term loan to fund the cash portion of the transaction  a million revolver to fund ongoing working capital needs  and draw down rights of up to million to refinance the outstanding subordinated convertible notes upon maturity 
the draw down rights are subject to certain operational and indebtedness milestones 
the company believes that internally generated funds  together with available cash  together with the expected loans mainly for the financing the assets purchased from coherent and draw down rights will suffice over at least the next months to meet its present anticipated day to day operating expenses  materials  commitments  working capital and capital expenditure requirements 
effective corporate tax rate inflationary adjustments 
the company and laser industries are subject to the income tax law inflationary adjustments   which provides for an adjustment to taxable income for the effects of inflation based on the israeli consumer price index on that portion of shareholders equity not invested in inflation resistant assets 
approved enterprise 
the company and laser industries have each received approval for their investment programs in accordance with the law for the encouragement of capital investments  the company has chosen to receive its benefits through the alternative benefits program  and  as such  is eligible for various benefits 
these benefits include accelerated depreciation of fixed assets used in the investment programs  as well as a full tax exemption on undistributed income that is derived from the approved enterprise for a period of six years and reduced tax rates for an additional period of up to four years 
laser industries is entitled to a full tax exemption for a period of two years and reduced tax rates for an additional period of up to five years the rate is dependent on the percentage of non israeli shareholder ownership 
the benefits commence with the date on which taxable income is first earned 
income not derived from the approved enterprise is subject to tax at a rate of 
the tax exemption period for the company commenced in and the tax exemption period for laser industries has not yet commenced 
dividends paid out of income derived from the approved enterprise is subject to a withholding tax 
should dividends be paid out of income earned during the period of the tax holiday  such income will be subject to tax at the rate of 
the company does not anticipate paying dividends from income derived from the approved enterprise and any such earnings distributed upon dissolution will not subject the company to income taxes 
forward looking statements certain statements made in this report or made in press releases or in oral presentations made by the company s employees or agents reflect the company s estimates and beliefs and are intended to be  and are hereby identified as  forward looking statements for the purposes of the safe harbor provisions of the private securities litigation reform act of the company cautions readers that such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from those expected by the company or expressed in the company s forward looking statements 
these factors include  but are not limited to  the following uncertainty of market acceptance of the company s products  uncertainties with respect to obtaining regulatory approvals for new products or for the sale of existing products in new markets  uncertainties associated with the enforcement of intellectual property rights by the company and others  limited number of customers for the company s products  risks of downturns in economic conditions generally  and in the health care industry specifically  risks associated with competition and competitive pricing pressures  the occurrence of unanticipated events and circumstances  the inability of the company to integrate successfully its operations with those of cmg or any other business which the company may agree to acquire and thereby achieve anticipated cost savings and other synergies and be in a position to take advantage of potential opportunities for growth  and other risks described in the company s filings with the securities and exchange commission 
readers are cautioned not to place undue reliance on forward looking statements made in this annual report  or made in press releases or in oral presentations 
such forward looking statements reflect management s analysis only as of the date such statements are made and the company undertakes no obligation to revise publicly these forward looking statements to reflect events or circumstances that arise subsequently 
readers should carefully review the risk factors set forth above and described elsewhere in this document and in other documents the company files from time to time with the securities and exchange commission 
item a 
quantitative and qualitative disclosures about market risk the company maintains an investment portfolio which consists mainly of income securities with an average maturity of less than one year 
the portfolio consists of low risk corporate bonds and bank deposits 
the company s policy is generally to hold its fixed income investments until maturity and therefore the company would not expect its operating results or cash flows to be affected to any significant degree by a sudden change in market interest rates on its securities portfolio 
the company has fixed rate long term debt of approximately million 
the company believes that a material decrease in interest rates would not have a material impact on the fair value of this debt 
the company has foreign subsidiaries  which sell and manufacture its products in various markets 
as a result  the company s earnings and cash flows are exposed to fluctuation in foreign currency exchange rates 
the company attempts to limit this exposure by selling and linking its products mostly to the united states dollar 
the company also enters into foreign currency hedging transactions to protect the dollar value of its non dollar denominated trade receivables  mainly in jpy  british sterling and euro 
the gains and losses on these transactions are included in the statement of operations in the period in which the changes in the exchange rate occur 
there can be no assurance that such activities or others will eliminate the negative financial impact of currency fluctuations 
indeed  such activities may have adverse impact on earnings 
the company does not hedge transactions nor does it use derivative financial instruments for trading purposes 

